Loews Corp’s Amgen AMGN Stock Holding History

Loews Corp’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,139	Closed	-$222K	–	143
2018 Q4	$222K	Hold	1,139	–	–	﹤0.01%	124
2018 Q3	$236K	Hold	1,139	–	–	﹤0.01%	123
2018 Q2	$210K	Buy	+1,139	New	+$201K	﹤0.01%	131

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Loews Corp's AMGN Position: Q1 2019 in Review

Loews Corp sold out of Amgen (AMGN) in Q1 2019, closing a stake of 1,139 shares — an estimated $222K sold.

Loews Corp first reported a position in AMGN in Q2 2018 and held it in 3 quarters. The position peaked at $236K in Q3 2018. 1,886 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

Loews Corp reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
Loews Corp sold 1,139 Amgen shares in Q1 2019, an estimated $222K.
Loews Corp first reported a position in Amgen in Q2 2018 and held it in 3 quarters.
Loews Corp's Amgen position peaked at $236K in Q3 2018.
1,886 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Loews Corp's 13F filing for Q1 2019, filed 13 May 2019.